Navigation Links
The conception of Anya, a period-free contraceptive pill

A contraceptive pill intended for consumption without a break is threatening to compete with the conventional oral contraceptive pill//. The pill, named Anya, manufactured by Wyeth Pharmaceuticals, is awaiting approval by health Canada, which will enable women to give a merry slip to the monthly period! Currently unavailable in neither United States nor Canada, Anya is undergoing a testing period marked by extensive clinical trials.

This pill is the first of its kind that is required to be taken daily without a lapse. Christine Derzko, an obstetrician and gynecologist from St. Michael's Hospital in Toronto, who is a keen supporter of the technique in the pill, expressed the extent of relief it would bring to women, who suffer acute menstruation discomfort.

A two-year study on Anya conducted on 79 women revealed that nearly 80% of the 79 women confirmed cessation in the bleeding. About 5 percent reported slight bleeding and spotting. According to researchers, Anya encompasses the same measure of risks like that of a traditional oral contraceptive.

This too is not without criticism, a body that does not support the unnatural cessation of menstrual cycle, say the study has not completely gauged the permanent health implications of using a period-free contraceptive. The lurking fear of breast cancer, or lowered bone density for women on the pill on long durations, is still very much on top of mind. The long term side effects need to be studied extensively before the pill can be considered absolutely safe.


Page: 1

Related medicine news :

1. Acupuncture for conception
2. Will anxiety regarding fertility treatment affect the chances of conception?
3. Autism: Symposium to Discuss Myths and Misconceptions
4. Misconceptions Put AIDS Patients In Tight-Spot
5. Misconception on Treatment Options among Prostate Cancer Patients
6. Misconceptions About Eating Eggs Busted
7. Misconceptions About Pet Owners Health Condition Revealed
8. Rajasthan Launches Programs to Overcome Misconceptions About Childbirth
9. Another injectable contraceptive Pill approved by FDA
10. Male contraceptive in trial
11. Hormone contraceptives lead to bone problems
Post Your Comments:

(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: